Have an innovative idea and not sure how the patenting process works? Join D2R and Lavery to learn how patent strategy supports scientific impact and how early choices impact downstream commercialization value when bringing life science innovations to market.

Designed to be accessible without sacrificing rigor, this session equips researchers and research administrators with a clearer understanding of how patent strategy supports scientific impact - and how early choices can materially affect downstream value and commercialization to bring life sciences innovations to market.

Date & Time: Tuesday, May 5 2026, from 10:00am to 11:30am

Location:

• In-person attendees: D2R Office (1010 Sherbrooke Street O, Suite 1800, Lovelace Conference Room) Space is limited!
• Virtual attendees: online on Zoom.

Serge Shahinian, Ph.D.

Partner - Patent Agent - Co-leader of the Intellectual Property Group

Serge Shahinian is a partner and patent agent in Lavery’s intellectual property group. He has been practicing in the intellectual property field since 2000, following prior doctoral and post-doctoral training in biochemistry, biology, and genetics.

Serge’s patent practice includes the areas of biotechnology, pharmaceutical and chemical, covering a wide range of related technologies in the health, agricultural, food, environmental and industrial sciences. His practice includes the procurement of patent rights, providing opinions and counselling in patentability, validity and infringement matters, as well as providing support concerning patent matters in litigation, transactions and financing in the biotechnology and pharmaceutical sectors.